Related Experiment Video
Updated: May 18, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive
M Díaz-Beyá1, A Navarro, G Ferrer
1Department of Hematology, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Abstract:
Acute myeloid leukemia (AML) with t(8;16)(p11;p13) (t(8;16) AML) has unique clinico-biological characteristics, but its microRNA pattern is unknown. We analyzed 670 microRNAs in seven patients with t(8;16) AML and 113 with other AML subtypes. Hierarchical cluster analysis showed that all t(8;16) AML patients grouped in an independent cluster. Supervised analysis revealed a distinctive signature of 94-microRNAs, most of which were downregulated, including miR-21 and cluster miR-17-92. The mRNA expression analysis of two known transcription factors of these microRNAs (STAT3 and c-Myc, respectively) showed significant downregulation of STAT3 (P=0.04). A bioinformatic analysis showed that 29 of the downregulated microRNAs might be regulated by methylation; we treated a t(8;16) AML sample with 5-aza-2'-deoxycytidine (5-AZA-dC) and trichostatin A and found that 27 microRNAs were re-expressed after treatment. However, there was no difference in methylation status between t(8;16) and other AML subtypes, either overall or in the microRNA promoter. Cross-correlation of mRNA and microRNA expression identified RET as a potential target of several microRNAs. A Renilla-luciferase assay and flow cytometry after transfection with pre-microRNAs confirmed that RET is regulated by miR-218, miR-128, miR-27b, miR-15a and miR-195. In conclusion, t(8;16) AML harbors a specific microRNA signature that is partially epigenetically regulated and targets RET proto-oncogene.
Insights
Acute myeloid leukemia with t(8;16) has a unique microRNA signature, with many downregulated microRNAs. This epigenetic regulation partially targets the RET proto-oncogene.
Area of Science:
- Hematology
- Molecular Biology
- Epigenetics
Background:
- Acute myeloid leukemia (AML) with the t(8;16) chromosomal translocation presents unique clinical and biological features.
- The specific microRNA expression profile in t(8;16) AML remains largely uncharacterized.
Purpose of the Study:
- To identify the distinct microRNA signature in t(8;16) AML.
- To investigate the epigenetic regulation of these microRNAs and their potential targets.
Main Methods:
- MicroRNA profiling of 7 t(8;16) AML patients and 113 other AML subtypes using hierarchical and supervised cluster analysis.
- Analysis of mRNA expression for STAT3 and c-Myc, bioinformatic analysis for methylation-regulated microRNAs, and in vitro epigenetic modulation using 5-aza-2'-deoxycytidine and trichostatin A.
- Cross-correlation of mRNA and microRNA expression, followed by functional validation using Renilla-luciferase assays and flow cytometry to confirm RET proto-oncogene regulation.
Main Results:
- t(8;16) AML patients exhibited a distinct microRNA signature, clustering independently.
- A signature of 94 microRNAs was identified, predominantly downregulated, including miR-21 and the miR-17-92 cluster, with significant STAT3 downregulation.
- Epigenetic analysis revealed that 27 of 29 potentially methylation-regulated microRNAs were re-expressed after treatment with epigenetic modifiers, and RET proto-oncogene was confirmed as a target regulated by specific microRNAs (miR-218, miR-128, miR-27b, miR-15a, miR-195).
Conclusions:
- t(8;16) AML possesses a specific microRNA signature that is partly regulated by epigenetic mechanisms.
- The RET proto-oncogene is a key target of this microRNA signature in t(8;16) AML.
Related Concept Videos
Abnormal Proliferation
Non-LTR Retrotransposons
Induced Pluripotent Stem Cells
Somatic cells are...
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

